Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Five modifiable risk factors are associated with cardiovascular disease and death from any cause. Studies using individual-level data to evaluate the regional and sex-specific prevalence of the risk factors and their effect on these outcomes are lacking. METHODS: We pooled and harmonized individual-level data from 112 cohort studies conducted in 34 countries and 8 geographic regions participating in the Global Cardiovascular Risk Consortium. We examined associations between the risk factors (body-mass index, systolic blood pressure, non-high-density lipoprotein cholesterol, current smoking, and diabetes) and incident cardiovascular disease and death from any cause using Cox regression analyses, stratified according to geographic region, age, and sex. Population-attributable fractions were estimated for the 10-year incidence of cardiovascular disease and 10-year all-cause mortality. RESULTS: Among 1,518,028 participants (54.1% of whom were women) with a median age of 54.4 years, regional variations in the prevalence of the five modifiable risk factors were noted. Incident cardiovascular disease occurred in 80,596 participants during a median follow-up of 7.3 years (maximum, 47.3), and 177,369 participants died during a median follow-up of 8.7 years (maximum, 47.6). For all five risk factors combined, the aggregate global population-attributable fraction of the 10-year incidence of cardiovascular disease was 57.2% (95% confidence interval [CI], 52.4 to 62.1) among women and 52.6% (95% CI, 49.0 to 56.1) among men, and the corresponding values for 10-year all-cause mortality were 22.2% (95% CI, 16.8 to 27.5) and 19.1% (95% CI, 14.6 to 23.6). CONCLUSIONS: Harmonized individual-level data from a global cohort showed that 57.2% and 52.6% of cases of incident cardiovascular disease among women and men, respectively, and 22.2% and 19.1% of deaths from any cause among women and men, respectively, may be attributable to five modifiable risk factors. (Funded by the German Center for Cardiovascular Research (DZHK); ClinicalTrials.gov number, NCT05466825.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“As well as the significant improvement in diabetic control, cardiometabolic risk was also improved by a significant reduction in SBP which was recorded across the cohort, specifically for those who had one or more co-existing medical conditions and for those who had a diagnosis of T2D of less than 6 years29.”
From mHealth low carbohydrate dietary intervention ameliorates glycaemic profile, blood pressure and weight status in people with type 2 diabetes (2025) · cites this paper as [29]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mice: Multivariate Imputation by Chained Equations in R
Buuren, S. V., & Groothuis-Oudshoorn, K. (2011) · Journal of Statistical Software · doi:10.18637/jss.v045.i03 · Cited by 13,870
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
Roth, G. A., Mensah, G. A., Johnson, C. O., Addolorato, G., Ammirati, E., Baddour, L. M., Barengo, N. C., Beaton, A. Z., Benjamin, E. J., Benziger, C. P., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.010 · Cited by 11,449
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Sabatine, M. S., Giugliano, R. P., Keech, A. C., Honarpour, N., Wiviott, S. D., Murphy, S. A., Kuder, J. F., Wang, H., Liu, T., Wasserman, S. M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1615664 · Cited by 6,138 · cited 1×
“Although very low non-HDL cholesterol concentrations are related to reduced CVD events, 25,26 some observations point towards higher all-cause mortality rates in individuals with very low levels at least in longer-term follow-up.”
(2010) · University of Twente Research Information · Cited by 6,037
Auditory and non-auditory effects of noise on health
Basner, M., Babisch, W., Davis, A., Brink, M., Clark, C., Janssen, S., & Stansfeld, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61613-x · Cited by 2,473 · cited 1×
“Environmental and exposomal factors such as physical activity 18 , alcohol consumption 28 , air pollution 29 , climate and noise 30 , educational level 3 or psychosocial risk factors including depression 31 impact CVD risk.”
Global burden of blood-pressure-related disease, 2001
Lawes, C. M., Hoorn, S. V., & Rodgers, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60655-8 · Cited by 2,330 · cited 3×
“While tobacco consumption is strongly associated with premature mortality, elevated blood pressure and cholesterol are more specifically related to CVD. 7 A tailored reduction in the burden of CVD and all-cause mortality for persons and populations can be achieved with better understanding of the region-and sex-specif…”
InfluentialEfficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
Robinson, J. G., Farnier, M., Krempf, M., Bergeron, J., Luc, G., Averna, M., Stroes, E. S., Langslet, G., Raal, F. J., El Shahawy, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501031 · Cited by 2,296 · cited 1×
“Although very low non-HDL cholesterol concentrations are related to reduced CVD events, 25,26 some observations point towards higher all-cause mortality rates in individuals with very low levels at least in longer-term follow-up.”
The Global Burden of Cardiovascular Diseases and Risk
Vaduganathan, M., Mensah, G. A., Turco, J. V., Fuster, V., & Roth, G. A. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.11.005 · Cited by 2,217
Cited by
Items 601–700 of 980
Ali, S. A., Vinding, N. E., Butt, J. H., Krøll, J., Larsson, J. E., Schou, M., Fosbøl, E. L., Løgstrup, B. B., Schjødt, I., Jhund, P. S., et al. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4667612
Li, Y., Yuyang, C., Mai, B., Xia, K., Haiyang, X., Danying, G., Wenqing, T., & Xie, S. L. (2024) · Research Square · doi:10.21203/rs.3.rs-3807107/v1
Child Marriage and Cardiovascular Risk: An Application of the Non-laboratory Framingham Risk Score
Datta, B. K., Ansa, B. E., Saucier, A., Pandey, A., Haider, M. R., Puranda, R., Adams, M. K., & Coffin, J. S. (2024) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-023-00620-2
Hypertension artérielle : ce qui a changé en 2023
Wuerzner, G., Ponte, B., & Péchère-Bertschi, A. (2024) · JMIG · doi:10.53738/revmed.2024.20.859.252
Raising awareness of cardiovascular diseases: A silent killer in South Africa
Qhayiya, F. M. (2024) · Journal of Cardiovascular Medicine and Cardiology · doi:10.17352/2455-2976.000203
Herz und Blut: klonale Hämatopoese
Dimmeler, S., & Zeiher, A. M. (2024) · Herz · doi:10.1007/s00059-024-05237-2
Wirkung beeinflussbarer Risikofaktoren auf kardiovaskuläre Erkrankungen und Mortalität
(2024) · Gefäßmedizin Scan - Zeitschrift für Angiologie Gefäßchirurgie diagnostische und interventionelle Radiologie · doi:10.1055/a-2241-1323
Amir, M. A., Amir, M. A., Kumar, A., & Arsal, S. A. (2024) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2024.102525
Un repaso a las novedades en hipertensión 2023: morbimortalidad, objetivos, fármacos y alcohol 0,0
CAMPS, M. B., Borrell, J. T., & Nadal, O. R. (2024) · Actualización en Medicina de Familia · doi:10.55783/amf.s200308
Blood pressure and the hypertension care cascade in The Gambia: Findings from a nationwide survey
Jobe, M., Mactaggart, I., Hydara, A., Kim, M. J., Bell, S., Kotanmi, B., Badjie, O., Prentice, A. M., & Burton, M. J. (2024) · Journal of Clinical Hypertension · doi:10.1111/jch.14806
Management of Obesity Disorders in Childhood and Adolescence
Kühnen, P. (2023) · Endocrinology · doi:10.1007/978-3-030-18901-3_14-1
Tada, H., Sakata, K., Usui, S., & Takamura, M. (2024) · Journal of Coronary Artery Disease · doi:10.7793/jcad.30.23-00023
Enhancing Outcomes Through Preoperative Risk Evaluation in Colorectal Cancer SurgeryPreprint
Li, J., Zhao, H., & Liu, J. (2024) · Research Square · doi:10.21203/rs.3.rs-4264261/v1
New Insights into Risk Factors for Postoperative Infections in Colorectal CancerPreprint
Li, J., Zhao, H., & Liu, J. (2024) · Research Square · doi:10.21203/rs.3.rs-4262701/v1
Rodrigues, L. F. (2024) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.39.2024.tde-14062024-153116
Why is this important? Collateral effects at personal, environmental, and national levels
Hoffmann, M. W. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-29839-4.00001-9
PERFIL EPIDEMIOLÓGICO DO LABORATÓRIO DE HEMODINÂMICA DO HOSPITAL SÃO LUCAS
Brustolin, L. M., Rodrigues, M. B., Barbosa, R. V., Michelon, I. C., & de Almeida, R. M. D. S. S. A. (2024) · Revista Multidisciplinar do Nordeste Mineiro · doi:10.61164/rmnm.v6i1.2405
Maaniitty, E., Sinisilta, S., Jalkanen, J., Vasankari, T., Biancari, F., Gunn, J. M., Jalkanen, S., Airaksinen, J. K. E., Hollmén, M., & Kiviniemi, T. (2024) · International Journal of Cardiology Cardiovascular Risk and Prevention · doi:10.1016/j.ijcrp.2024.200307 · Cited by 1
Home Blood Pressure in Health and Disease
af Geijerstam, P. (2024) · Linköping University medical dissertations · doi:10.3384/9789180756563
Eghbalian, M., Akbari, H., Moradalizadeh, S., Norouzi, M., Nasab, H., Karamali, M., Imani, M., Zahiri, H., & Raei, M. (2024) · Research Square · doi:10.21203/rs.3.rs-4638076/v1
Kazemi, T., Bidokhti, A., Riahi, S. M., & Pirayesh, Z. (2023) · Sālnāmah va āmār. · doi:10.61186/jbums.30.3.289
The Impact of Cardiovascular Disease Is Different Even Within Southeast Asia
Yamamoto, K. (2024) · JACC Asia · doi:10.1016/j.jacasi.2024.06.005
It is time to get all the job done: For patients’ sake
Avogaro, A. (2024) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2024.07.033
Hei, Y., Lee, Y. S., & Kim, Y. S. (2024) · The Korean Journal of Sports Medicine · doi:10.5763/kjsm.2024.42.3.220
Cheng, J. S.-C., Thorndike, A. N., & Yi, S. S. (2024) · medRxiv · doi:10.1101/2024.08.27.24312681
Rodriguez, R. E. C. (2024) · Revista Cuidado y Salud Pública · doi:10.53684/csp.v4i1.105
Mood swings, abdominal obesity, and heart failure: A Mediation Mendelian Randomization StudyPreprint
Wu, Y., Gao, X., Fang, Q., Shen, T., Tan, J., Li, Q., & Huang, J. Y. (2024) · Research Square · doi:10.21203/rs.3.rs-4879626/v1
Diagnose des akuten Koronarsyndroms
Thießen, N., & Schnabel, R. B. (2024) · Angewandte Nuklearmedizin · doi:10.1055/a-2359-0809
Kardiovaskuläre Prävention im Alter
Müller‐Werdan, U., Rosada, A., & Norman, K. (2024) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-024-02355-8
Kardiovaskuläre Prävention in Sachsen-Anhalt: Notwendigkeit und neue Perspektiven
Müller, P., Herzog, M. J., Duderstadt, Y., Kunz, M., Lechner, K., Meyer, F., Schmeißer, A., Meißler, S., Ahrens, D., Neumann, K., et al. (2024) · Die Innere Medizin · doi:10.1007/s00108-024-01789-x
Geschlechtersensible Gefäßmedizin
Freisinger, E. (2024) · Springer Reference Medizin · doi:10.1007/978-3-662-61379-5_212-1
Screening for abdominal aortic aneurysm in the world and in Russia
Балахонова, Т. В., Ershova, A. I., Genkel, V. V., Garbuzova, E. V., Drozdova, L. Y., Svetlikov, A. V., Akchurin, R. S., Shalnova, S. A., Boytsov, S. A., & Drapkina, O. M. (2024) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2024-6013
Gorostegi-Anduaga, I., Tous‐Espelosin, M., & Maldonado‐Martín, S. (2024) · Blood Pressure Monitoring · doi:10.1097/mbp.0000000000000731
Heng, K. J., Loong, S. S. E., Chew, H. S. J., Yap, J. J. L., Cader, F. A., Prajapati, D., Lee, D., Shariff, R. E. R., Cuenza, L. R., Honda, S., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae666.2621
Hundemer, G. L., & Sood, M. M. (2024) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000546
Management of Obesity Disorders in Childhood and Adolescence
Kühnen, P. (2024) · Endocrinology · doi:10.1007/978-3-030-23709-7_14
Graf, A. V., Маклакова, А. С., Maslova, M. V., Krushinskaya, Y. V., Guseva, A. A., & Соколова, Н. А. (2024) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093024050272
Analysis of the Prevalence of Cardiovascular Risk Factors in Patients with Chronic Hepatitis C
Rajewski, P., Małgorzata, P., Kwiatkowska, J., Fadzina-Abukhowska, A., Nowicka-Matuszewska, A., Kozielewicz, D., Dybowska, D., Olczak, A., & Cieściński, J. (2024) · Journal of Cardiovascular Medicine and Cardiology · doi:10.17352/2455-2976.000210
role of lipoprotein a in cardiac risk stratification and evaluation of hypolipemizing treatment
Maciąg, M., Garbacz, K., Pasztelan, M., Marczak, A., Walczuk, J. K. V., Pulikowski, J., Słaboń, M., Sobczyk, M., Muca, A., & Baran, J. (2024) · Quality in Sport · doi:10.12775/qs.2024.31.55297
Could this be the first step towards a tailor-made lifestyle modification?
Higuchi, K., & Ohishi, M. (2024) · Hypertension Research · doi:10.1038/s41440-024-02003-z
Carrillo-Larco, R. M., & Hambleton, I. R. (2024) · Revista Panamericana de Salud Pública · doi:10.26633/rpsp.2024.59
Graf, A. V., Маклакова, А. С., Maslova, M. V., Krushinskaya, Y. V., Guseva, А. А., & Соколова, Н. А. (2024) · Российский физиологический журнал им И М Сеченова · doi:10.31857/s0869813924100051
Hao, H., Geng, H., & Ma, M. (2025) · International Journal of General Medicine · doi:10.2147/ijgm.s499194
Strategies to Overcome Metabolic Syndrome and Related Diseases
(2025) · Frontiers research topics · doi:10.3389/978-2-8325-5556-9
ABO and RhD blood groups as contributors to dyslipidaemia – a cross-sectional study
Mickelsson, M., Ekblom, K., Stefansson, K., Liv, P., Själander, A., Näslund, U., & Hultdin, J. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02444-6
Ismailova, M. A., Afanaseva, A. D., Garbuzova, E. V., Шрамко, В. С., Симонова, Г. И., & Ragino, Y. I. (2025) · Ateroscleroz · doi:10.52727/2078-256x-2024-20-4-385-396
Maqsood, B., & Gul, F. (2025) · National Radiology Journal of Pakistan · doi:10.37184/nrjp.3007-5181.1.20
Zamora, A. N., Campero, M. I., Garcia, D. M., Chavez, D. M., & King, A. C. (2025) · BMC Public Health · doi:10.1186/s12889-025-21885-3
Aparício, D., Costa, M., & Marques, R. (2025) · Cureus · doi:10.7759/cureus.80004
Saito, Y., & Kobayashi, Y. (2025) · International Journal of Cardiology · doi:10.1016/j.ijcard.2025.133155
Warncke, K., Hofer, S. E., von Sengbusch, S., Ermer, U., Niemeyer, M., Lemmer, A., Hilgard, D., Welters, A., Holl, R. W., & Eckert, A. J. (2025) · BMC Pediatrics · doi:10.1186/s12887-025-05434-w
The potential of erythrocyte-mimic nanoparticles in the treatment of cardiovascular diseases
Zhu, N., & Yang, J. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2485674
Chu, W.-L., Lee, M.-C., Hsu, Y.-J., Huang, C., & Chien, Y.-J. (2025) · Universal library of medical and health sciences. · doi:10.70315/uloap.ulmhs.2025.0302001
de Moraes, L. S., Filho, A. O. F. M., Liermann, L. C., de Castilhos, C. B., de Matos, L. A., Feóli, A. M. P., Marques, A. Y. C., Borges, L. R., & Abib, R. T. (2025) · Psychology Health & Medicine · doi:10.1080/13548506.2025.2458252
A Chrono-nutritional Perspective on Cereal and Snack Research Case Studies
Masutomi, H., Furutani, A., Ueda, S., Shibata, S., & Ishihara, K. (2025) · Nippon Eiyo Shokuryo Gakkaishi · doi:10.4327/jsnfs.78.95
White matter matters in chronic vestibular syndrome: Implications for prevention
Hofmann, J. B., Egli, M., Ertl, M., & Brémovà-Ertl, T. (2025) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2025.123524
Мищенко, Л. А., & Matova, O. O. (2025) · HYPERTENSION · doi:10.22141/2224-1485.18.1.2025.375
Epidemiological research and prevention of cardiovascular disease
Jørgensen, T., Pisinger, C. H., Aadahl, M., Toft, U., Kårhus, L. L., & Linneberg, A. R. (2025) · Ugeskrift for Læger · doi:10.61409/v09240611
Alkouri, O. A., Albikawi, Z. F., Al-Bashaireh, A. M., Saifan, A. R., Alrabadi, N., Qaladi, O., Alharbi, A., Jarrah, M., Abuadas, M. H., Hammoudeh, A. J., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-6360446/v1
Karimi, F., Darabı, F., & Ezzati, F. (2025) · Discover Social Science and Health · doi:10.1007/s44155-025-00215-3
Михайловна, Ч. Е., Минувалиевна, Х. Н., Karyakin, A. A., Евгеньевна, К. О., & Попов, В. В. (2025) · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук · doi:10.29413/abs.2025-10.2.15
Das Herz des Alters – das Altern des Herzens
Alber, H. F. (2025) · Springer eBooks · doi:10.1007/978-3-662-70207-9_4
Kurt, B., Rau, M., Hartmann, O., Bergmann, A., Reugels, M., Just, S., Wenzl, F. A., Moellmann, J., Spießhöfer, J., Milzi, A., et al. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.120220 · Cited by 1
Role of Community Pharmacies in Spreading the Concept of Vascular Aging in Daily Clinical Practice
Rodilla, E., Aichberger, M., Ardelt, F., Baixauli, V. J., Cinza‐Sanjurjo, S., Fernández, M. S., Fernández, V., García‐Ortiz, L., Guzmán-Aguayo, A. K., Hametner, B., et al. (2025) · Artery Research · doi:10.1007/s44200-024-00066-4
Old and New Molecular Targets in the Treatment of Hypertension
Martinez, L. (2025) · Nephrology Self-Assessment Program · doi:10.58483/nsap.00542024
Huang, Y., Hu, Y., Tong, B., Yang, W., Cai, Q., Wang, B., Lang, X., Liu, Z., Haiyan, X., Yuejin, Y., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5266363
Goupil, R., Tsuyuki, R. T., Santesso, N. A., Terenzi, K. A., Habert, J., Cheng, G., Gysel, S. C., Bruneau, J., Leung, A. A. C., Campbell, N. R. C., et al. (2025) · Canadian Medical Association Journal · doi:10.1503/cmaj.241770-f · Cited by 1
Söderberg, S., Taki, H., Kowlessur, S., Shaw, J. E., Magliano, D. J., Tamošiūnas, A., Alberti, K. G. M. M., Zimmet, P., & Tuomilehto, J. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-087693
DETERMINATION OF CARDIOVASCULAR DISEASE RISK FACTORS KNOWLEDGE LEVEL IN UNIVERSITY EMPLOYEES
Yalçın, G. A., & Yıldırım, N. (2025) · İnönü Üniversitesi Sağlık Hizmetleri Meslek Yüksek Okulu Dergisi · doi:10.33715/inonusaglik.1569050
Type 2 MI a legitimate efficacy endpoint in cardiovascular trials? A critical appraisal
van Bruggen, F. H., & Luijendijk, H. J. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1564432
Yin, Y., & Shi, L. (2025) · Research Square · doi:10.21203/rs.3.rs-6894190/v1
Muldasheva, N. A., Zaydullin, I. I., Karimov, D. O., Каримова, Л. К., Shapoval, I. V., & Gimaeva, Z. F. (2025) · Yakut Medical Journal · doi:10.25789/ymj.2025.90.16
Pedicino, D., & Volpe, M. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf398
Li, J., Yang, H. B., Zhang, Y., Yan, J., Yan, J., & Zhang, Y. (2025) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2025.106037
An Improved Infectious Disease Risk Prediction Model Based on Attention Mechanism
Wang, Y., Wan, Y., Chen, Q., Lei, X., Wang, Y., Sun, G., Li, X., & Hu, H. (2024) · Artificial Intelligence and Cloud Computing Conference (AICCC) · doi:10.1145/3719384.3719398
Herz-Kreislauf-Risiko bei Menschen mit HIV
Platte, M., & Eßer, S. (2025) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-025-5054-9
Evaluating the Effectiveness of Systemic Arterial Hypertension
Filho, M. F. G. J. (2025) · International Journal of Health Science · doi:10.22533/at.ed.15952525070714
Mancini, G. B. J. (2025) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2025.07.005
SMuRF-less patients: orphans of atherosclerotic disease prevention
Schmid, J. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf464
Cycling of metabolic states and metabolites as drivers of atherosclerosis
Krautter, F., & Fisher, E. A. A. (2025) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000001004
Song, K., Lee, E., Lee, H. S., Lee, H. C., Kim, J. Y., Choi, Y., & Chae, H. W. (2025) · Endocrine · doi:10.1007/s12020-025-04336-2
Anti-Thrombotic Effects of Coprinus comatus Fibrinolytic Enzyme in Zebrafish
Jing, Y., Wang, J., He, Y., Liu, Z., & Liu, X. (2025) · Nutrients · doi:10.3390/nu17142358
“Globally, thrombus formation represents a leading cause of mortality and morbidity [1,2].”
Sex and gender differences in cardiovascular diseases
Raparelli, V., Proietti, M., Romiti, G. F., & Basili, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-27398-8.00008-3
Thamman, R., Berrocal, I., Massardo, T., Peix, A., Páez, D., & Bullock-Palmer, R. P. (2025) · Current Cardiology Reports · doi:10.1007/s11886-025-02252-5
Aktuelle Leitlinien zum Vorhofflimmern: Was empfehlen AWMF und ESC?
Wolfes, J., & Eckardt, L. (2025) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-2498-1456
Wang, J., Ye, Z., & Xie, Q. (2025) · Medicine · doi:10.1097/md.0000000000043706 · Cited by 1
“[11,12] Epidemiological studies show that the occurrence and development of cardiovascular diseases are not only closely related to biological factors.”
The synergistic treatment of heart and kidney disease
Mahfoud, F., Götzinger, F., Kramann, R., Marx, N., & Schwenger, V. (2026) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2025.0131 · Cited by 1
Association Between Neck-to-Limb Length Ratio and Cardiovascular Events in a Chinese Population
Li, X., Hu, T., Xu, Y., Lu, X., Su, Y., Xiao, Y., Wang, Y., Ma, X., & Bao, Y. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s543163
Goupil, R., Tsuyuki, R. T., Santesso, N. A., Terenzi, K. A., Habert, J., Cheng, G., Gysel, S. C., Bruneau, J., Leung, A. A. C., Campbell, N. R. C., et al. (2025) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/17151635251352537
Trends in cardiovascular risk in Peru: A 10-year population-based analysis (2015–2024)
Diaz‐Arocutipa, C., Nombera-Aznaran, N., Benites-Zapata, V. A., Kikushima-Alcantara, P., & Herrera‐Añazco, P. (2025) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2025.103155
Гакова, Е. И., Gakova, A. A., Bessonova, M. I., Kayumova, M. M., & Викторовна, А. Е. (2025) · Russian Journal of Preventive Medicine · doi:10.17116/profmed20252808134
Fedulaev, Y. N., Sargsyan, A. J., Yakushev, Y. Y., Goryainova, S. V., Cheshkina, P. V., Shakerova, R. R., Васильевич, Г. К., Sapozhnikov, S. A., & Nv, O. (2025) · Medical alphabet · doi:10.33667/207856312025173943
What Can Atherosclerosis Imaging Teach Us About Healthy Vascular Aging?
Blankstein, R., Magnussen, C., & Nasir, K. (2025) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2025.07.014
Xiang, Y., Hui, S., Yan, Z., Nie, H., & Guo, C. (2025) · Medicine · doi:10.1097/md.0000000000044143
“[4,5] Additionally, coronary artery syndrome, usually caused by coronary artery stenosis or obstruction leading to myocardial ischemia, is a major risk factor for CHD. [6] In China, the prevalence and mortality rates of CHD continue to rise, imposing a significant economic and public health burden…”
Adinarayana, S., Jadala, V. C., Samantray, O. P., Rao, K. Y., Choudhury, N., & Raju, S. H. (2025) · International Conference on Soft Computing for Security Applications (ICSCSA) · doi:10.1109/icscsa66339.2025.11170759
Suta, S., Pinsawas, B., Surawit, A., Ophakas, S., Wang, Y., Du, Y. Y., Shen, X., Pasookhush, P., Mongkolsucharitkul, P., Soonkum, T., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-7577991/v1
Most CVD Events Are Preceded by Traditional Risk Factors
Pagidipati, N. J. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.08.030
Baccouch, W., Benameur, N., & Labidi, S. (2025) · Lecture notes in networks and systems · doi:10.1007/978-981-96-6929-5_31
Liuzzo, G., & Pedicino, D. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf701
Metadata
- Authors
- The Global Cardiovascular Risk Consortium
- Affiliations
- University Medical Center Hamburg-Eppendorf (DE)
- Corresponding author
- The Global Cardiovascular Risk Consortium
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2023-10-05
- Volume
- 389
- Issue
- 14
- Pages
- 1273-1285
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC10589462
- OpenAlex
- W4386194106
- Cited by
- 909
- References
- 35
- Citations by year
- 2026: 285 · 2025: 359 · 2024: 242 · 2023: 23
- FWCI
- 47.54
- Type
- journal article
- Language
- en
- Open access
- Licence
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by-nc-nd)
- Research Portal (Queen's University Belfast) (publishedVersion, cc-by)
- PubMed Central (acceptedVersion, cc-by)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Lithuanian University of Health Sciences (submittedVersion, cc-by)
- Digital Commons-TMC (Texas Medical Center) (submittedVersion)
- HAL (submittedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion, other-oa)
- BOA (University of Milano-Bicocca) (submittedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- IrInSubria (University of Insubria) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Duo Research Archive (University of Oslo) (submittedVersion)
- STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
- Funders
- European Union AFFECT-EU (Horizon 2020, No. 847770)
- German Center for Cardiovascular Research (not applicable)
- European Union MORGAM (Biomed, BMH4-CT98-3183)
- European Union GenomEUtwin (FP5, QLG2-CT-2002-01254)
- European Union ENGAGE (FP7, HEALTH-F4-2007-201413)
- European Union CHANCES (FP7, HEALTH-F3-2010-242244)
- European Union BiomarCaRE (FP7, HEALTH-F2-2011-278913)
- European Union euCanSHare (Horizon 2020, No. 825903)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- modifiable risk factors, cardiovascular disease, all-cause mortality, population attributable fraction, body mass index, systolic blood pressure, non-HDL cholesterol, smoking, diabetes mellitus, sex differences, regional variation, global cardiovascular risk, cohort studies, cardiovascular disease incidence, women's health
- MeSH terms
- Heart Disease Risk Factors, Cardiovascular Diseases, Diabetes Mellitus, Female, Humans, Male, Middle Aged, Risk Factors, Smoking, Internationality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.